Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinomas of the Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT00855634
What this trial is testing

Resection in Pancreatic Cancer With Minimal Metastatic Disease or Venous Infiltration Trial at Technische Universität München

Who this might be right for
Pancreatic Cancer
Technical University of Munich 355
Early research (Phase 1)Active Not RecruitingNCT00878163
What this trial is testing

GDC-0449 and Erlotinib Hydrochloride With or Without Gemcitabine Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer or Solid Tumors That Cannot Be Removed by Surgery

Who this might be right for
Adult Solid NeoplasmPancreatic Acinar Cell CarcinomaPancreatic Ductal Adenocarcinoma+2 more
National Cancer Institute (NCI) 55
Post-approval studies (Phase 4)Looking for participantsNCT07262957
What this trial is testing

Preventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Including Hydrocortisone, Octreotide, and the Teres Ligament Patch (PANENCA)

Who this might be right for
Pancreas Head CancerPancreas AdenocarcinomaIPMN, Pancreatic+7 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 400
Not applicableUnknownNCT06893536
What this trial is testing

Impact of Perioperative Nutritional Status and Management in the Context of Resectable Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Adenocarcinoma
University Hospital, Strasbourg, France 100
Not applicableStudy completedNCT01580709
What this trial is testing

Endoscopic Retrograde Cholangiopancreatography (ERCP) Based Sampling of Indeterminate Bile Duct Strictures

Who this might be right for
Indeterminate Bile Duct Stricture
Medical University of South Carolina 48
Testing effectiveness (Phase 2)Study completedNCT01433263
What this trial is testing

Clinical Study of BYM338 for the Treatment of Unintentional Weight Loss in Patients With Cancer of the Lung or the Pancreas

Who this might be right for
Cachexia
Novartis Pharmaceuticals 57
Testing effectiveness (Phase 2)Active Not RecruitingNCT04115163
What this trial is testing

Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic AdenocarcinomaStage IV Pancreatic Cancer AJCC v8
Anne Noonan 67
Early research (Phase 1)Looking for participantsNCT06126406
What this trial is testing

Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes（CAR-T） for CEA Positive Advanced Malignant Solid Tumors

Who this might be right for
Gastric CancerColon CancerRectal Cancer+5 more
Chongqing Precision Biotech Co., Ltd 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07108504
What this trial is testing

Efficacy and Safety of LM-302 Combined With Gemcitabine CLDN 18.2 Positive Unresectable Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic CancerChemotherapy Effect
Shanghai Zhongshan Hospital 30
Testing effectiveness (Phase 2)UnknownNCT04010552
What this trial is testing

Nalirinox Neo-pancreas RAS Mut ctDNA Study

Who this might be right for
Resectable Pancreatic Ductal Adenocarcinoma
Fundación de investigación HM 20
Not applicableEnded earlyNCT01071434
What this trial is testing

Feasibility of Using Real-time Cine-MRI for Treating Moving & Deforming Tumors

Who this might be right for
Pancreatic CancerLiver CancerLung Cancer+7 more
Stanford University 5
Early research (Phase 1)Study completedNCT05788484
What this trial is testing

CDX-585 in Patients With Advanced Malignancies

Who this might be right for
Non-small Cell Lung CancerGastric CancerHead and Neck Cancer+11 more
Celldex Therapeutics 20
Early research (Phase 1)Study completedNCT02658214
What this trial is testing

Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors

Who this might be right for
Small Cell Lung CarcinomaCarcinoma, Squamous Cell of Head and NeckStomach Neoplasms+7 more
AstraZeneca 32
Not applicableStudy completedNCT02000999
What this trial is testing

Diagnosis of Bile Duct Strictures

Who this might be right for
Bile Duct StrictureCholangiocarcinomaPancreatic Cancer+1 more
Washington University School of Medicine 110
Testing effectiveness (Phase 2)Study completedNCT02318784
What this trial is testing

Carfilzomib for the Treatment of Patients With Advanced Neuroendocrine Cancers

Who this might be right for
Neuroendocrine Cancer
SCRI Development Innovations, LLC 62
Testing effectiveness (Phase 2)WithdrawnNCT00226746
What this trial is testing

Efficacy Study of Gemcitabine, Paclitaxel, and Irradiation in the Treatment of Pancreatic Cancer

Who this might be right for
Carcinoma, Pancreatic Ductal
New York Presbyterian Brooklyn Methodist Hospital
Testing effectiveness (Phase 2)Study completedNCT00005832
What this trial is testing

S9924 R115777 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
SWOG Cancer Research Network 58
Early research (Phase 1)Study completedNCT02685553
What this trial is testing

Near Infrared Technology and Laparoscopic Resection of Pancreatic Lesions: the COLPAN Project

Who this might be right for
Pancreatic Neuroendocrine TumorsClear Cell Renal CarcinomaSolid Pseudopapillary Tumors of the Pancreas
Universita di Verona 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07808567
What this trial is testing

Evaluation of the Efficacy and Safety of Neoadjuvant Therapy in Patients With Surgically Resectable Pancreatic Adenocarcinoma.

Who this might be right for
Pancreatic Adenocarcinoma ResectableNon MetastaticECOG Performance Status Score of 0 or 1
Gustave Roussy, Cancer Campus, Grand Paris 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT02568267
What this trial is testing

Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)

Who this might be right for
Breast CancerCholangiocarcinomaColorectal Cancer+13 more
Hoffmann-La Roche 534
Next Page